Covestor’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Covestor's DNA Position: Q3 2026 in Review
Covestor held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2464.
Covestor first reported a position in DNA in Q3 2022 and has held it in 17 quarters since. 128 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Covestor held 1 share of Ginkgo Bioworks worth $0 as of Q3 2026.
- Covestor left its Ginkgo Bioworks share count unchanged in Q3 2026.
- Ginkgo Bioworks made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2464 holding.
- Covestor first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 17 quarters since.
- 128 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.